Do We Need to Rethink the Epidemiology and Healthcare Utilization of Parkinson's Disease in Germany?
Sebastian Heinzel(Christian-Albrechts-Universität zu Kiel), Volker Eric Amelung(Ingenieurgesellschaft Auto und Verkehr (Germany)), Sebastian Binder, Jens Volkmann(University of Würzburg), Ingmar Wellach(Albertinen Diakoniewerk), Lennart Hickstein(Utrecht University), Walter Maetzler(Christian-Albrechts-Universität zu Kiel), Niklas Schmedt(Institute for Applied Economic Research), Dirk Woitalla(Ruhr University Bochum), Heinz Herbst, Michael Lorrain(Gerresheimer (Germany)), Daniela Berg(Christian-Albrechts-Universität zu Kiel), G. Petersen(Grünenthal Group (Germany)), Georg Ebersbach(Neurologisches Fachkrankenhaus für Bewegungsstörungen/Parkinson)
Cited by 78
Related Papers
MDS clinical diagnostic criteria for Parkinson's disease
|Movement Disorders|2015|7.4k
Multicenter Analysis of Glucocerebrosidase Mutations in Parkinson's Disease
|New England Journal of Medicine|2009|2.1k
Genome-wide association study reveals genetic risk underlying Parkinson's disease
|Nature Genetics|2009|2k
EAACI Food Allergy and Anaphylaxis Guidelines: diagnosis and management of food allergy
|Allergy|2014|1.4k
MDS research criteria for prodromal Parkinson's disease
|Movement Disorders|2015|1.3k